Live Breaking News & Updates on Hyderabad based bharat biotech international

Stay informed with the latest breaking news from Hyderabad based bharat biotech international on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Hyderabad based bharat biotech international and stay connected to the pulse of your community

NYC Gets First J&J Shots; Italy Blocks Vaccines: Virus Update

NYC Gets First J&J Shots; Italy Blocks Vaccines: Virus Update
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

Australia , Hungary , Finland , New-york , United-states , Milan , Lombardia , Italy , Central-valley , Beijing , China , California

EU Starts Sputnik Review; Milan Faces New Curbs: Virus Update

EU Starts Sputnik Review; Milan Faces New Curbs: Virus Update
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

Germany , Hungary , Finland , Australia , Milan , Lombardia , Italy , Tokyo , Japan , Hong-kong , Texas , United-states

Indian Vaccine Effective; Record Deaths in Brazil: Virus Update

Indian Vaccine Effective; Record Deaths in Brazil: Virus Update
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

Sao-paulo , Sãpaulo , Brazil , New-york , United-states , Japan , Tokyo , Germiston , Gauteng , South-africa , Texas , Sunak

With 81% Effective Data, Covaxin Could Boost Vaccine Uptake

With 81% Effective Data, Covaxin Could Boost Vaccine Uptake
With 81% Effective Data, Covaxin Could Boost Vaccine Uptake
That's better than Bharat Biotech's guidance last year of around 60% and the country's benchmark of 50% for vaccines targeting the novel coronavirus.
The findings cement Bharat Biotech's claims of the vaccine being safe
A home-grown coronavirus vaccine that generated controversy when it was granted emergency approval before finishing its final stage testing has shown to provide strong protection against Covid-19 in an interim analysis of an advanced clinical trial.
Covaxin, which was co-developed by Hyderabad-based Bharat Biotech International Ltd. and the Indian Council of Medical Research, showed an efficacy of 81% in those without prior infection after a second dose, the company said in a statement Wednesday. That's better than Bharat Biotech's guidance last year of around 60% and the country's benchmark of 50% for vaccines targeting the novel coronavirus.

India , New-delhi , Delhi , Brazil , Bharat , Serum-institute-of-india-ltd , Indian-council-of-medical-research , Ocugen-inc , Bharat-biotech-international-ltd , Astrazeneca-plc , Effective-data

Study: Indian coronavirus vaccine approved in January found to be 81 percent effective

A coronavirus vaccine made in India that drew controversy over its speedy approval has been found to be 81 percent effective in fighting the virus.

India , Bharat , Krishna-ella , Suchitra-ella , Bharat-biotech-international , Indian-council-of-medical-research , Hyderabad-based-bharat-biotech-international , Indian-council , Medical-research , Bharat-biotech , Bharat-biotech-chair-krishna-ella , Covid-19-vaccination-in-india

Tests on kids: Expert panel asks Bharat Biotech to submit Covaxin efficacy data first

Covaxin is already approved for use in India for adults in a clinical trial mode based on the safety and immunogenicity data the company submitted

Hindustan , India-general , India , Hyderabad , Andhra-pradesh , Ukraine , Pune , Maharashtra , Bharat , Maksym-stepanov , Krishna-ella , Bharat-biotech-international-on

4,600 active Covid cases in Pune district, 212 patients in city under oxygen treatment

475 people tested positive for Covid, taking the tally to 3,89,147. Two people died of Covid. The death toll is at 9,096.

Pune , Maharashtra , India , Chinchwad , Pimpri , Bharat , Bhagwan-pawar , Ashish-bharti , Serum-institute-of-india-covishield , Pune-municipal-corporation , Bharat-biotech-international-ltd , Photo-credit

Asian vaccination tips sought

Confounded by the problems Western nations are encountering in their Covid-19 vaccination programmes, the Philippines will look to Asian nations on how to inoculate millions of people against the deadly respiratory disease that has already claimed more than 10,600 Filipino lives.

Philippines , United-kingdom , Vietnam , Republic-of , Sweden , Philippine , Benguet , India , Filipino , Bharat , Swedish , Vietnamese

Don't Get COVID Jab If You Have Medical Conditions: Bharat Biotech

Don't Get COVID Jab If You Have Medical Conditions: Bharat Biotech
Jan 19, 2021, 14:55 IST
Bharat Biotech on Monday warned that those who have weaker immunity and people with allergies must not take the Covaxin shot. Earlier, the government had said that the vaccine could be taken by the patients who are on immuno-suppressants or suffer from immune deficiency. They said that if such people takes vaccine then the immune response would be less effective. Cancer patients who are on chemotherapy, HIV-positive individuals and those who are on steroids are typically immune-suppressed.
India has started vaccinating lakhs of people using two Covid vaccines - Covaxin and the Oxford-Astrazeneca vaccine Covishield produced by Serum Institute of India.

India , Bharat , Bharat-biotech-international-ltd , Serum-institute-of-india , Bharat-biotech , Serum-institute , Hyderabad-based-bharat-biotech-international , Covaxin , Covid-19 , Coronavirus-vaccine , Know-who-shouldn-039t-take-covaxin-shot

India and smug mediocrity

Read more about India and smug mediocrity on Business Standard. Indian democracy is equating excellence with elitism

India , Pune , Maharashtra , Bharat , Oxford-astrazeneca , Jaimini-bhagwati , National-institute-of-virology , Bharat-biotech-international , Indian-council-for-medical-research , Serum-institute-of-india , Hyderabad-based-bharat-biotech-international , Indian-council